Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anke Redeker

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|January 26, 2018
The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious DoseAnke Redeker, Ester B M Remmerswaal, Esmé T I van der Gracht, et al.
International Journal of Cancer|September 25, 2003
Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumorsSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Molecular Immunology|November 28, 2017
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responsesSara M Mangsbo, Erika A K Fletcher, Wendy W C van Maren, et al.
Cancer Gene Therapy|July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
The Journal of Infectious Diseases|September 9, 2010
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responsesMuriel van den Hende, Anke Redeker, Kitty M C Kwappenberg, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|January 26, 2018
The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious DoseAnke Redeker, Ester B M Remmerswaal, Esmé T I van der Gracht, et al.
International Journal of Cancer|September 25, 2003
Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumorsSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Molecular Immunology|November 28, 2017
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responsesSara M Mangsbo, Erika A K Fletcher, Wendy W C van Maren, et al.
Cancer Gene Therapy|July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
The Journal of Infectious Diseases|September 9, 2010
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responsesMuriel van den Hende, Anke Redeker, Kitty M C Kwappenberg, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Pageof 3